Roberts Brandi 4

What Happened

• Brandi Roberts, Chief Financial Officer of Definium Therapeutics (DFTX), sold 3,013 common shares on 2026-06-25 at $45.03 per share, generating proceeds of $135,675. The filing reports the disposition (sale).

Key Details

• Transaction date: 2026-06-25; Filing date (Form 4): 2026-06-26.
• Price per share: $45.03; Total proceeds: $135,675.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: Sale made to satisfy withholding tax obligations related to the settlement of vested restricted stock units pursuant to sell-to-cover elections under a Rule 10b5-1 plan adopted May 30, 2025 (F1).
• Timeliness: Filed the day after the transaction (appears timely based on provided dates).

Context

• This was a tax-withholding "sell-to-cover" disposition under a pre-existing 10b5-1 plan, a routine administrative sale when restricted stock vests. Such transactions are common and do not necessarily signal a change in the insider's view of the company.